28B5 Wickstrom, Eric - Thomas Jefferson University - Thomas Jefferson University
exw114

Eric Wickstrom, PhD

Contact Dr. Wickstrom

233 South 10th Street
209 & 219 Bluemle Life Sciences Building
Philadelphia, PA 19107-5541

(215) 955-4578
(215) 955-4580 fax

Most Recent Peer-reviewed Publications

  1. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
  2. Nanotube devices for digital profiling: A focus on cancer biomarkers and circulating tumor cells.
  3. Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA
  4. Effects of hypoxanthine substitution in peptide nucleic acids targeting KRAS2 oncogenic mRNA molecules: Theory and experiment
  5. Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass
  6. VPAC1 receptors for imaging breast cancer: A feasibility study
  7. Synthesis, physicochemical and biochemical studies of anti-IRS-1 oligonucleotides containing carborane and/or metallacarborane modification
  8. Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells
  9. Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics Study
  10. Nanotube devices for digital profiling of cancer biomarkers and circulating tumor cells
  11. Diagnostic and therapeutic applications of carbon nanotubes
  12. Erratum to: Targeting apoptosis for optical imaging of infection
  13. Targeting apoptosis for optical imaging of infection
  14. Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells
  15. Three dimensional projection environment for molecular design and surgical simulation
  16. Micro- and nanotechnology approaches for capturing circulating tumor cells
  17. Genetic and molecular approaches to imaging breast cancer
  18. Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates
  19. Physiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing mice
  20. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [111In]DOTAn-Poly(diamidopropanoyl)m- KRAS2 PNA- d (Cys-Ser-Lys-Cys) nanoparticles
0